Literature DB >> 19093899

Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders.

Madaswamy S Muthu1, Sanjay Singh.   

Abstract

Novel technology in the nanomedicine field is expected to develop innovative products as targeted drug-delivery approaches. Targeted drug delivery of various drugs for the treatment of cancer, AIDS and brain disorders is the primary research area in which nanomedicines have a major role and need. This review is concerned with emerging targeted nanomedicines (polymeric nanoparticles, solid lipid nanoparticles, polymeric micelles, dendrimers, liposomes, gold nanoparticles and magnetic nanoparticles) and multifunctional carriers capable of combining targeted drug delivery and imaging (polymeric micelles, dendrimers and magnetic nanoparticles) in the field of pharmaceutical applications. The significant toxicity issues associated with these nanomedicines are also explored here.

Entities:  

Mesh:

Year:  2009        PMID: 19093899     DOI: 10.2217/17435889.4.1.105

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  38 in total

1.  Pharmacotoxicology of monocyte-macrophage nanoformulated antiretroviral drug uptake and carriage.

Authors:  Rafael F Bressani; Ari S Nowacek; Sangya Singh; Shantanu Balkundi; Barrett Rabinow; Joellyn McMillan; Howard E Gendelman; Georgette D Kanmogne
Journal:  Nanotoxicology       Date:  2010-12-22       Impact factor: 5.913

Review 2.  Future Perspectives of Radionanomedicine Using the Novel Micelle-Encapsulation Method for Surface Modification.

Authors:  Yun-Sang Lee; Yong-Il Kim; Dong Soo Lee
Journal:  Nucl Med Mol Imaging       Date:  2015-08-07

Review 3.  The role of nanotechnology in the treatment of viral infections.

Authors:  Lavanya Singh; Hendrik G Kruger; Glenn E M Maguire; Thavendran Govender; Raveen Parboosing
Journal:  Ther Adv Infect Dis       Date:  2017-07-05

4.  Neuromolecular imaging, a nanobiotechnology for Parkinson's disease: advancing pharmacotherapy for personalized medicine.

Authors:  P A Broderick; L Wenning; Y-S Li
Journal:  J Neural Transm (Vienna)       Date:  2016-10-28       Impact factor: 3.575

5.  Multi-stimuli responsive Cu2S nanocrystals as trimodal imaging and synergistic chemo-photothermal therapy agents.

Authors:  Aby Cheruvathoor Poulose; Srivani Veeranarayanan; M Sheikh Mohamed; Yutaka Nagaoka; Rebeca Romero Aburto; Trevor Mitcham; Pulickel M Ajayan; Richard R Bouchard; Yasushi Sakamoto; Yasuhiko Yoshida; Toru Maekawa; D Sakthi Kumar
Journal:  Nanoscale       Date:  2015-05-14       Impact factor: 7.790

Review 6.  More effective nanomedicines through particle design.

Authors:  Jin Wang; James D Byrne; Mary E Napier; Joseph M DeSimone
Journal:  Small       Date:  2011-06-22       Impact factor: 13.281

7.  Docetaxel-loaded liposomes: preparation, pH sensitivity, pharmacokinetics, and tissue distribution.

Authors:  Hong Zhang; Rui-ying Li; Xia Lu; Zhen-zhen Mou; Gui-mei Lin
Journal:  J Zhejiang Univ Sci B       Date:  2012-12       Impact factor: 3.066

Review 8.  Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs.

Authors:  Simi Gunaseelan; Krishnan Gunaseelan; Manjeet Deshmukh; Xiaoping Zhang; Patrick J Sinko
Journal:  Adv Drug Deliv Rev       Date:  2009-11-24       Impact factor: 15.470

9.  Therapeutic efficacy of poly (lactic-co-glycolic acid) nanoparticles encapsulated ivermectin (nano-ivermectin) against brugian filariasis in experimental rodent model.

Authors:  Mohammad Ali; Mohammad Afzal; Meenakshi Verma; Shailja Misra Bhattacharya; F J Ahmad; Mohammad Samim; M Z Abidin; A K Dinda
Journal:  Parasitol Res       Date:  2013-12-24       Impact factor: 2.289

10.  Binding fullerenol C(60)(OH)(24) to dsDNA.

Authors:  Mariana Pinteala; Andrei Dascalu; Cezar Ungurenasu
Journal:  Int J Nanomedicine       Date:  2009-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.